Status:
COMPLETED
Rural Tailored COVID-19 Communication to Promote SARS-CoV-2 Antibody Testing in Saliva
Lead Sponsor:
Michigan State University
Collaborating Sponsors:
Johns Hopkins University
National Cancer Institute (NCI)
Conditions:
SARS-CoV2 Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study seeks to evaluate communication strategies for better encouraging understanding and uptake of salivary SARS-CoV-2 antibody testing among individuals residing in rural Northern Michigan. Thi...
Detailed Description
Rural Americans are at higher risk of many severe COVID-19 related health outcomes. These disparities are likely to endure given lower vaccination uptake in many rural communities, and also the contin...
Eligibility Criteria
Inclusion
- White, 18 or older
Exclusion
- All who do not meet inclusion criteria
Key Trial Info
Start Date :
May 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 14 2023
Estimated Enrollment :
264 Patients enrolled
Trial Details
Trial ID
NCT06085547
Start Date
May 4 2023
End Date
November 14 2023
Last Update
January 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Flint Journal Building
Flint, Michigan, United States, 48502